anchor: The Food and Drug Administration (FDA) performed a cost and benefit analysis evaluating the economic impact of the final rule.
positive: As per the FDA, a cost and benefit analysis was created and had influence over the final rule.
negative: The FDA did not bother to conduct a cost and benefit analysis and as a result the final rule was not known to have any economic impact.